More

    Rhizen Pharmaceuticals Announces US FDA Acceptance of its IND Application for RP7214 in SARS-CoV-2 Infection

    Must Read

    About 122 percent vaccination at four centers of the district on fourth day

    Health corona fighters will be vaccinated in 5 places on Saturday As Covid vaccination...

    Vadodara woman president suspended for committing anti-party act

    Vadodara City Congress has now suspended Vadodara Mahila Congress president Saraswatiben Desai for committing anti-party acts in...

    Covid 19 cases reached 22942 in Vadodara after 63 new cases on Friday

    Total 95 discharged from hospital taking the total to 21768 The number of positive...

    Phase 1 Clinical Trial of RP7214 Set to Begin Early December 2020

    Rhizen Pharmaceuticals S.A., an associate company of Alembic Pharmaceuticals Ltd., which is a clinical-stage oncology-focussed biopharmaceutical company, announced the approval of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) to study its oral DHODH inhibitor for SARS-CoV-2 infection.

    The company announced that initial study shall evaluate single ascending doses of RP7214 in healthy volunteers and that dosing is expected to commence in early December 2020. The company also announces positive feedback from the FDA during its pre-IND discussion on its plans to follow-up this study with a multiple-ascending dose study in Covid-19 patients.

    Dihydroorotate dehydrogenase (DHOHD) is a key enzyme involved in pyrimidine biosynthesis in the cell. RP7214 is potentially a best-in-class selective DHODH inhibitor that has shown potent inhibition of Covid-19 viral replication. RP7214 has also been studied extensively across multiple inflammation models where it has demonstrated excellent anti-inflammatory activity.

    Further, the IND-enabling preclinical studies have shown RP7214 to be orally available, safe and tolerable with predictable dose-linear pharmacokinetics. The host-based mechanism of RP7214 could allow complementary combinations with direct acting anti-viral drugs, while the broad anti-inflammatory action could potentially mitigate the cytokine mediated inflammatory symptoms typically seen in SARS-CoV-2 & other viral infections.

    Swaroop Vakkalanka, President & CEO of Rhizen Pharmaceuticals said “There is an exceptional need for oral antiviral drugs that are suitable for Covid-19 treatment across all hospital and out-patient settings. We are pleased to advance RP7214 into a Phase 1 clinical trial for the treatment of Covid-19 under a US FDA IND. RP7214 has a unique preclinical profile, high oral bioavailability, robust anti-viral potency and broad anti-inflammatory role, that we expect will translate in the clinic and support its eventual development as a potential treatment for Covid-19.”

    Talking on this development, Pranav Amin- the Managing Director of Alembic Pharmaceuticals Ltd. said, “Its exciting development that our team Rhizen is working on and we are hoping on, an oral retroviral, which will add a new dimension to treatment of Covid 19”.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    Latest News

    Bhajan singer Narendra Chanchal passed away

    Popular Bhajan singer Narendra Chanchal passed away on Friday, i.e. 22nd January 2021. He was 80. The...

    Vadodara woman president suspended for committing anti-party act

    Vadodara City Congress has now suspended Vadodara Mahila Congress president Saraswatiben Desai for committing anti-party acts in the party amid political unrest...

    Covid 19 cases reached 22942 in Vadodara after 63 new cases on Friday

    Total 95 discharged from hospital taking the total to 21768 The number of positive cases in Vadodara reached 22942...

    Money put inside bank locker eaten by termites in Vadodara

    Woman account holder demand compensation Your money is no longer safe even in a bank locker. A case in...

    RSP leader Rajesh Ayre along with supporters joined BJP

    RSP leader Rajesh Ayre along with his whole team joined BJP on Friday. Vadodara BJP President Dr. Vijay Shah and other senior...

    More Articles Like This

    - Advertisement -